☰

David Z. D'Argenio - Publications

Affiliations: 
Biomedical Engineering University of Southern California, Los Angeles, CA, United States 
Area:
Biomedical
Tree Info Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hu S, D'Argenio DZ. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling. Journal of Pharmacokinetics and Pharmacodynamics. PMID 32500362 DOI: 10.1007/S10928-020-09691-3  0.356
2020 Chen W, Boras B, Sung T, Yu Y, Zheng J, Wang D, Hu W, Spilker ME, D'Argenio DZ. A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor. Journal of Pharmacokinetics and Pharmacodynamics. PMID 32162138 DOI: 10.1007/S10928-020-09680-6  0.331
2018 Park AYJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. PMID 29914949 DOI: 10.1128/Aac.00550-18  0.321
2017 Bensman TJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses to Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. PMID 28784670 DOI: 10.1128/Aac.00988-17  0.314
2015 Weiss M, Tura A, Kautzky-Willer A, Pacini G, D'Argenio DZ. Human insulin dynamics in women: a physiologically based model. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00113.2015. PMID 26608654 DOI: 10.1152/Ajpregu.00113.2015  0.301
2015 Wu LS, Rower JE, Burton JR, Anderson PL, Hammond KP, Baouchi-Mokrane F, Everson GT, Urban TJ, D'Argenio DZ, Kiser JJ. Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection. Antimicrobial Agents and Chemotherapy. 59: 2179-88. PMID 25645847 DOI: 10.1128/Aac.04618-14  0.334
2013 Zhu R, Zheng Y, Putnam WS, Visich J, Eisner MD, Matthews JG, Rosen KE, D'Argenio DZ. Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. The Aaps Journal. 15: 559-70. PMID 23413101 DOI: 10.1208/S12248-013-9463-9  0.378
2012 Wu CC, D'Argenio D, Asgharzadeh S, Triche T. TARGETgene: a tool for identification of potential therapeutic targets in cancer. Plos One. 7: e43305. PMID 22952662 DOI: 10.1371/Journal.Pone.0043305  0.493
2012 Kay BP, Hsu CP, Lu JF, Sun YN, Bai S, Xin Y, D'Argenio DZ. Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab. Journal of Pharmacokinetics and Pharmacodynamics. 39: 577-90. PMID 22932917 DOI: 10.1007/s10928-012-9269-x  0.451
2012 Kiser JJ, Zhu R, DʼArgenio DZ, Cotton MF, Bobat R, McSherry GD, Madhi SA, Carey VJ, Seifart HI, Werely CJ, Fletcher CV. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Therapeutic Drug Monitoring. 34: 446-51. PMID 22695364 DOI: 10.1097/Ftd.0B013E31825C4Bc3  0.348
2012 Beringer PM, Owens H, Nguyen A, Benitez D, Rao A, D'Argenio DZ. Pharmacokinetics of doxycycline in adults with cystic fibrosis. Antimicrobial Agents and Chemotherapy. 56: 70-4. PMID 22024822 DOI: 10.1128/Aac.05710-11  0.326
2012 Zhu R, Kiser JJ, Seifart HI, Werely CJ, Mitchell CD, D'Argenio DZ, Fletcher CV. The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid. Journal of Clinical Pharmacology. 52: 511-9. PMID 21558457 DOI: 10.1177/0091270011402826  0.403
2010 Wu CC, Asgharzadeh S, Triche TJ, D'Argenio DZ. Prediction of human functional genetic networks from heterogeneous data using RVM-based ensemble learning. Bioinformatics (Oxford, England). 26: 807-13. PMID 20134029 DOI: 10.1093/Bioinformatics/Btq044  0.5
2010 Beumer JH, Eiseman JL, Gilbert JA, Holleran JL, Yellow-Duke AE, Clausen DM, D'Argenio DZ, Ames MM, Hershberger PA, Parise RA, Bai L, Covey JM, Egorin MJ. Abstract 4549: Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice Cancer Research. 70: 4549-4549. DOI: 10.1158/1538-7445.Am10-4549  0.302
2009 Wang X, Schumitzky A, D'Argenio DZ. Population Pharmacokinetic/Pharmacodyanamic Mixture Models via Maximum a Posteriori Estimation. Computational Statistics & Data Analysis. 53: 3907-3915. PMID 20161085 DOI: 10.1016/J.Csda.2009.04.017  0.495
2008 Wang J, Weiss M, D'Argenio DZ. A note on population analysis of dissolution-absorption models using the inverse Gaussian function. Journal of Clinical Pharmacology. 48: 719-25. PMID 18359921 DOI: 10.1177/0091270008315956  0.349
2008 Beumer JH, Eiseman JL, Parise RA, Florian JA, Joseph E, D'Argenio DZ, Parker RS, Kay B, Covey JM, Egorin MJ. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. Cancer Chemotherapy and Pharmacology. 62: 457-64. PMID 18008070 DOI: 10.1007/S00280-007-0625-2  0.486
2007 Wang X, Schumitzky A, D'Argenio DZ. Nonlinear Random Effects Mixture Models: Maximum Likelihood Estimation via the EM Algorithm. Computational Statistics & Data Analysis. 51: 6614-6623. PMID 19756256 DOI: 10.1016/J.Csda.2007.03.008  0.482
2006 Zhou Z, Rodman JH, Flynn PM, Robbins BL, Wilcox CK, D'Argenio DZ. Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents. Antimicrobial Agents and Chemotherapy. 50: 2686-94. PMID 16870759 DOI: 10.1128/Aac.01637-05  0.559
2003 Xu L, Eiseman JL, Egorin MJ, D'Argenio DZ. Physiologically-based pharmacokinetics and molecular pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite in tumor-bearing mice. Journal of Pharmacokinetics and Pharmacodynamics. 30: 185-219. PMID 14571691 DOI: 10.1023/A:1025542026488  0.318
2000 Drusano GL, D'Argenio DZ, Preston SL, Barone C, Symonds W, Lafon S, Rogers M, Prince W, Bye A, Bilello JA. Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir Antimicrobial Agents and Chemotherapy. 44: 1655-1659. PMID 10817724 DOI: 10.1128/Aac.44.6.1655-1659.2000  0.362
1997 D'Argenio DZ, Park K. Uncertain pharmacokinetic/pharmacodynamic systems: Design, estimation and control Control Engineering Practice. 5: 1707-1716. DOI: 10.1016/S0967-0661(97)10025-9  0.338
1995 Williams LE, Odom-Maryon TL, Liu A, Chai A, Raubitschek AA, Wong JY, D'Argenio DZ. On the correction for radioactive decay in pharmacokinetic modeling. Medical Physics. 22: 1619-26. PMID 8551986 DOI: 10.1118/1.597421  0.307
1993 D'Argenio DZ, Rodman JH. Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective Journal of Pharmacokinetics and Biopharmaceutics. 21: 223-251. PMID 8229682 DOI: 10.1007/Bf01059772  0.33
1990 D'Argenio DZ. Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments Mathematical Biosciences. 99: 105-118. PMID 2134510 DOI: 10.1016/0025-5564(90)90141-K  0.31
1990 Shadmehr R, D'Argenio DZ. A Neural Network for Nonlinear Bayesian Estimation in Drug Therapy Neural Computation. 2: 216-225. DOI: 10.1162/Neco.1990.2.2.216  0.337
1989 Katz D, D'Argenio DZ. Stochastic control of pharmaco-kinetic systems. Open-loop feedback strategies Ifac Proceedings Series. 391-396. DOI: 10.1016/S1474-6670(17)57585-0  0.36
1989 D'Argenio DZ, Maneval DC. Estimation approaches for modeling sparse data systems Ifac Proceedings Series. 61-67. DOI: 10.1016/S1474-6670(17)57535-7  0.351
1988 D'Argenio DZ, Schumitzky A, Wolf W. Simulation of linear compartment models with application to nuclear medicine kinetic modeling Computer Methods and Programs in Biomedicine. 27: 47-54. PMID 3409681 DOI: 10.1016/0169-2607(88)90102-2  0.323
1986 Katz D, D'Argenio DZ. Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibiotics Journal of Pharmacokinetics and Biopharmaceutics. 14: 523-537. PMID 3806374 DOI: 10.1007/Bf01059659  0.342
1986 Brechner RR, D'Argenio DZ, Dahalan R, Wolf W. Noninvasive estimation of bound and mobile platinum compounds in the kidney using a radiopharmacokinetic model Journal of Pharmaceutical Sciences. 75: 873-877. PMID 3783454 DOI: 10.1002/Jps.2600750909  0.368
1983 D'Argenio DZ, Khakmahd K. Adaptive control of theophylline therapy: Importance of blood sampling times Journal of Pharmacokinetics and Biopharmaceutics. 11: 547-559. PMID 6668559 DOI: 10.1007/Bf01062211  0.333
1983 D'Argenio DZ, Katz D. Sampling strategies for noncompartmental estimation of mean residence time Journal of Pharmacokinetics and Biopharmaceutics. 11: 435-446. PMID 6668552 DOI: 10.1007/Bf01058960  0.336
1983 Katz D, D'Argenio DZ. Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies Biometrics. 39: 621-628. PMID 6652198 DOI: 10.2307/2531089  0.354
1981 D'Argenio DZ. Optimal sampling times for pharmacokinetic experiments Journal of Pharmacokinetics and Biopharmaceutics. 9: 739-756. PMID 7341758 DOI: 10.1007/Bf01070904  0.303
1979 D'argenio DZ, Schumitzky A. A program package for simulation and parameter estimation in pharmacokinetic systems Computer Programs in Biomedicine. 9: 115-134. PMID 761456 DOI: 10.1016/0010-468X(79)90025-4  0.332
Show low-probability matches.